J Korean Soc Endocrinol.  2005 Dec;20(6):597-607. 10.3803/jkes.2005.20.6.597.

Bone/Vascular Calcification: Signal Transduction Pathway and Calcification Related Genes

• Choi JY

• KMID: 1572442
• DOI: http://doi.org/10.3803/jkes.2005.20.6.597

Abstract

No Abstract available.

MeSH Terms

Signal Transduction*

Figure

• 

  Fig. 1

• 

  Fig. 2

• 

  Fig. 3

Reference

1. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res. 2005. 97:105–114.

2. Browner WS, Lui LY, Cummings SR. Association of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab. 2001. 86:631–637.

3. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Gene Dev. 1998. 12:1260–1268.

4. Kaden JJ, Bickelhaupt S, Grobholz R, Haase KK, Sarikoc A, Kilic R, Brueckmann M, Lang S, Zahn I, Vahl C, Hagl S, Dempfle CE, Borggrefe M. Receptor activator of nuclear factor kB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol. 2004. 36:57–66.

5. Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab. 2003. 88:1024–1028.

6. Shao J-S, Cheng S-L, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest. 2005. 115:1210–1220.

7. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005. 437:270–274.

8. Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, Smith DA, Boyd NL, Platt MO, Lassegue BL, Griendling KK, Jo H. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res. 2004. 95:773–779.

9. Towler DA, Bidder M, Latifi T, Coleman T, Semenkovich CF. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotien receptor-deficient mice. J Biol Chem. 1998. 273:30427–30434.

10. Bostrom K, Watson KE, Horn S, Worthman C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993. 91:1800–1809.

11. Dhore CR, Cleutjens J, Lutgens E, Cleutjens K, Geussens P, Kitslaar P, Tordoir J, Spronk H, Vermeer C, Daemen M. Differential expression of bone matrix regulatory proteins in human atherosclerotic plagues. Arterioscler Thromb Vasc Biol. 2001. 21:1998–2003.

12. Griethe W, Schmitt R, Bachmann S, Eckardt K-U, Schindler R. Bone morphogenetic protein-4 expression in vascular lesions of calciphylaxis. J Nephrol. 2003. 16:728–732.

13. Dorai H, Vukicevic S, Sampath TK. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol. 2000. 184:37–45.

14. Dorai H, Sampath TK. Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture. J Bone Joint Surg. 2001. 83:S70–S78.

15. Li T, Surendran K, Zawaideh MA, Mathew S, Hruska KA. Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Curr Opin Nephrol Hypertens. 2004. 13:417–422.

16. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessroy protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem. 1999. 274:584–594.

17. Zhao GQ. Consequence of knocking out BMP signaling in the mouse. Genesis. 2003. 35:43–56.

18. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS. Overexpression of an osteogenic morphogen in fibrodysplasia ossifcans progressiva. N Eng J Med. 1996. 335:555–561.

19. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd Je, Nichols WC, Trembath RC. Heterozygous germine mutations in BMPR2, endoding a TGF-β receptore, cuase familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet. 2000. 26:81–84.

20. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimborne MA Jr, Falb D, Huszar D. Role for Smad6 in development and homeostasis of the cardiovascular system. Nat Genet. 2002. 24:171–174.

21. Kopan R. Notch: a membrane-bound transcription factor. J Cell Sci. 2002. 115:1095–1097.

22. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev. 2001. 108:161–164.

23. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001. 89:1147–1154.

24. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits hyeprcholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002. 105:2660–2665.

25. McLarren KW, Lo R, Grbavec D, Thirunavukkarasu K, Karsenty G, Stifani S. The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1. J Biol Chem. 2000. 275:530–538.

26. Zamurovic N, Cappellen D, Rohner D, Susa M. Coordinated activation of Notch, wnt, and transforming growth factor-β signaling pathways in bone morphogenic protein 2-induced osteogenesis. J Biol Chem. 2004. 279:37704–37715.

27. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trast BJ, Kuo WL, Cochran J, Costa T, Pierpont ME, Rand EB, Piccoli DA, Hood L, Spinner NB. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997. 16:243–251.

28. Szweras M, Liu d, Partridge EA, Pawling J, Sukhu B, Clokie C, Jahnen-Dechent W, Tenenbaum HC, Swallow CJ, Grynpas MD, Dennis JW. a2-Hs glycoprotein/fetuin, a transforming growth factor-b/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem. 2002. 277:19991–19997.

29. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix γ-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem. 2002. 277:3926–3934.

30. Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, Renne T, Jahnen-Dechnet W. Structural basis of calcification inhibition by α2-HS glycoprotein/Fetuin-A. J Biol Chem. 2003. 278:13333–13341.

31. Luo G, Ducy P, Mckee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaenous calcification of arteries and cartilage in mice lacking matrix GLA prtoein. Nature. 1997. 386:78–81.

32. El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, McKee MD. Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res. 2003. 44:suppl.272–278.

33. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol. 1998. 18:1400–1407.

34. Munroe PB, Olgunturk RO, Fryns JP, VanMaldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999. 21:142–144.

35. Zebboudj AF, Imura M, Bostrom K. Matrix Gla protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem. 2003. 90:757–765.

36. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature. 1996. 382:448–452.

37. Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest. 2000. 105:915–923.

38. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol. 2002. 161:2035–2046.

39. Stefan C, Jansen S, Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trend Biochem Sci. 2005. 30:542–550.

40. Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S. Mutation in Npps in a mouse model of ossification of the posterio longitudinal ligament of the spine. Nat Genet. 1998. 19:271–273.

41. Johnson K, Polewski M, van Etten D, Terkeltaub R. Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arterioscler Throm Vasc Biol. 2005. 25:686–691.

42. Kuro-o M, Matsumaura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Jume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997. 390:45–51.

43. Suga T, Kurabayashi M, Sando Y, Ohyama Y, Maeno T, Maeno Y, Aizawa H, Matsumura Y, Kuwaki T, Kuro-O M, Nabeshima Y, Nagai R. Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol. 2000. 22:26–33.

44. Tsujikawa H, Kurotaki Y, Fujimori T, Fujuda K, Nabeshima Y. Klotho, a gene related to a syndrome resembling human premature agining, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol. 2003. 17:2393–2403.

45. Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science. 2005. 310:490–493.

46. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endo Rev. 1994. 15:439–461.

47. Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP. Different missense mutations at the tissue-nonspecific alkaline phsophatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci. 1992. 89:9924–9928.

48. Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn Sp, MacGregor GR. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet. 1995. 11:45–51.

49. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, MacGregor GR, Whyte MP. Alkaline phosphatase knock-out mice recaptitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res. 1999. 14:2015–2026.

50. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H. Beta-glycerophosphate accelerates calcificaiton in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995. 15:2003–2009.

51. Jono S, Nishizawa Y, Shioi A, Morii H. Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Artherioscler Thromb Vasc Biol. 1997. 17:1135–1142.

52. Kizu A, Shioi A, Jono S, Koyama H, Okuno Y, Nishizawa Y. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. J Cell Biochem. 2004. 93:1011–1019.

53. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells. Roles of tumor necrosis factor-α and oncostatin M derived from macrophages. Circ Res. 2002. 91:9–16.

54. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res. 2001. 88:954–960.

55. Spicer SS, Lewis SE, Tashian RE, Schulte BA. Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification. Am J Pathol. 1989. 134:947–954.

56. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000. 289:265–270.

57. Reichenberge E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanna C, Baur ST, Shiang R, Grange DK, Beighton P, Gardner J, Hamersma H, Sellars S, Ramesar R, Lidral AC, Sommer A, Raposo do Amaral CM, Gorlin RJ, Mulliken JB, Olsen BR. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet. 2001. 68:1321–1326.

58. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, Reginato A, Shiang R, Wright G, Netter P, Williams C, Kingsley DM. Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet. 2002. 71:933–940.

59. Rutsch F, Terkeltaub R. Deficiencies of physiologic calcification inhibitors and low-grade inflammation in arterial calcification: lessons for cartilage calcification. Joint Bone Spine. 2005. 72:110–118.

60. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol. 1996. 134:1255–1270.

61. Mavroidis M, Capetananki Y. Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy. Am J Pathol. 2002. 160:943–952.

62. Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, Biery NJ, Dietz HC, Sakai LY, Ramirez F. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci. 1999. 96:3819–3823.

63. Sugitani H, Wachi H, Mecham RP, Seyama Y. Accelerated calcification represses the expression of elastic fiber components and lysyl oxidase in cultured bovine aortic smooth muscle cells. J Atheroscler Thromb. 2002. 9:292–298.

64. Murshed M, harmey D, Millan JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Gene Dev. 2005. 19:1093–1104.